Iron deficiency in whole blood donors

Transfusion

Volumn 51, Issue 3, 2011, Pages 458-461

  Brittenham, Gary M ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN RECEPTOR;

ATTENTION DISTURBANCE; BLOOD DONOR; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CONCENTRATION LOSS; EDITORIAL; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; FATIGUE; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; IRON DEPLETION; IRON STORAGE; IRON THERAPY; MENSTRUATION; PREGNANCY; SEX RATIO;

BLOOD DONORS; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; IRON;

EID: 79952460918     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03062.x     Document Type: Editorial

References (52)

1. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Vij V, Simon TL. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011;51:511-22.
2. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-64. (Pubitemid 36857914)
3. Bullock GC, Delehanty LL, Talbot AL, Gonias SL, Tong WH, Rouault TA, Dewar B, Macdonald JM, Chruma JJ, Goldfarb AN. Iron control of erythroid development by a novel aconitase-associated regulatory pathway. Blood 2010;116:97-108.
4. Falkingham M, Abdelhamid A, Curtis P, Fairweather-Tait S, Dye L, Hooper L. The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis. Nutr J 2010;9:4.
5. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007;85:778-87. (Pubitemid 46393510)
6. Hinton PS, Sinclair LM. Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanemic athletes. Eur J Clin Nutr 2007;61:30-9. (Pubitemid 44921113)
7. Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 2006;46:1667-81. (Pubitemid 44435718)
8. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, Simon TL. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion 2010;50:1794-802.
9. Finch CA, Cook JD, Labbe RF, Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977;50:441-7. (Pubitemid 8180427)
10. Radtke H, Meyer T, Kalus U, Rocker L, Salama A, Kiesewetter H, Latza R. Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120. Transfusion 2005;45:5-10.
11. Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA 1981;245:2038-43. (Pubitemid 11099104)
12. American Association of Blood Banks. Standards for blood banks and transfusion services. Bethesda, MD: AABB; 2009.
13. Suitability of Donor, 21 CFR 640.3 (b) (3) (2010).
14. Skikne B, Lynch S, Borek D, Cook J. Iron and blood donation. Clin Haematol 1984;13:271-87. (Pubitemid 15192780)
15. Delaney M, Schellhase KG, Young S, Geiger S, Fink A, Mast AE. Blood center practice and education for blood donors with anemia. Transfusion 2010; doi: 10.1111/j.1537-2995.2010.02919.x.
16. Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion 2004;44:1417-26. (Pubitemid 39318975)
17. Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med 2008;18:13-27. (Pubitemid 351239317)
18. Sullivan JL. Blood donation may be good for the donor. Iron, heart disease, and donor recruitment. Vox Sang 1991;61:161-4.
19. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4. (Pubitemid 11111356)
20. Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997;314:793-4. (Pubitemid 27117051)
21. Salonen JT, Tuomainen TP, Salonen R, Lakka TA, Nyyssonen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Epidemiol 1998;148:445-51. (Pubitemid 28411101)
22. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-93. (Pubitemid 27404957)
23. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ. Blood donations and risk of coronary heart disease in men. Circulation 2001;103:52-7. (Pubitemid 32050435)
24. Meyers DG, Jensen KC, Menitove JE. A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion 2002;42:1135-9.
25. Zheng H, Cable R, Spencer B, Votto N, Katz SD. Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 2005;25:1577-83. (Pubitemid 41098924)
26. Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 2007;297:603-10.
27. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24. (Pubitemid 24118269)
28. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-8. (Pubitemid 24173715)
29. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-8. (Pubitemid 24026478)
30. Manttari M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, Frick MH. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 1994; 15:1599-603.
31. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10:441-8.
32. Bozzini C, Girelli D, Tinazzi E, Olivieri O, Stranieri C, Bassi A, Trabetti E, Faccini G, Pignatti PF, Corrocher R. Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem 2002;48:622-8. (Pubitemid 34261225)
33. Kervinen H, Tenkanen L, Palosuo T, Roivainen M, Manninen V, Manttari M. Serumiron, infection and inflammation; effects on coronary risk. Scand Cardiovasc J 2004;38:345-8. (Pubitemid 40123791)
34. van der A DL, Marx JJ, Grobbee DE, Kamphuis MH, Georgiou NA, van Kats-Renaud JH, Breuer W, Cabantchik ZI, Roest M, Voorbij HA, van der Schouw YT. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 2006;113:1942-9.
35. Galan P, Noisette N, Estaquio C, Czernichow S, Mennen L, Renversez JC, Briancon S, Favier A, Hercberg S. Serum ferritin, cardiovascular risk factors and ischaemic heart diseases: a prospective analysis in the SU.VI.MAX (SUpplementation en VItamines et Mineraux AntioXydants) cohort. Public Health Nutr 2006;9:70-4.
36. van der A DL, Rovers MM, Grobbee DE, Marx JJ, Waalen J, Ellervik C, Nordestgaard BG, Olynyk JK, Mills PR, Shepherd J, Grandchamp B, Boer JM, Caruso C, Arca M, Meyer BJ, van der Schouw YT. Mutations in the HFE gene and cardiovascular disease risk: an individual patient data metaanalysis of 53 880 subjects. Circ Cardiovasc Genet 2008;1:43-50.
37. Friedrich N, Milman N, Volzke H, Linneberg A, Jorgensen T. Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2874 subjects. Br J Nutr 2009;102:594-600.
38. Sun Q, Ma J, Rifai N, Franco OH, Rexrode KM, Hu FB. Excessive body iron stores are not associated with risk of coronary heart disease in women. J Nutr 2008;138:2436-41.
39. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999;99:852-4. (Pubitemid 29094295)
40. Ma J, Stampfer MJ. Body iron stores and coronary heart disease. Clin Chem 2002;48:601-3. (Pubitemid 34261222)
41. FB H. The iron-heart hypothesis: search for the ironclad evidence. JAMA 2007;297:639-41.
42. Sullivan JL. Blood donation without adequate iron depletion: an invalid test of the iron hypothesis. Circulation 2001;104:E149.
43. Sullivan JL. Stored iron and vascular reactivity. Arterioscler Thromb Vasc Biol 2005;25:1532-5. (Pubitemid 41098917)
44. Sullivan JL, Katz SD. Iron reduction and cardiovascular outcomes. JAMA 2007;297:2075. Author reply 2076.
45. Sullivan JL. Iron in arterial plaque: modifiable risk factor for atherosclerosis. Biochim Biophys Acta 2009;1790:718-23.
46. Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, Zacharski LR. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. J Vasc Surg 2010;51:1498-503.
47. Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts RB, Aylesworth C, Nemo G, Alving B. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion 2002;42:798-805.
48. Simon TL, Hunt WC, Garry PJ. Iron supplementation for menstruating female blood donors. Transfusion 1984;24:469-72. (Pubitemid 15193809)
49. Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keating LJ. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990;30:239-45. (Pubitemid 20112728)
50. Brittenham GM, Klein HG, Kushner JP, Ajioka RS. Preserving the national blood supply. Hematology Am Soc Hematol Educ Program 2001;422-32.
51. Simon TL. Iron, iron everywhere but not enough to donate. Transfusion 2002;42:664.
52. Food and Drug Administration, Center for Biologics Evaluation and Research, Blood Products Advisory Committee. Blood donor hemoglobin/hematocrit standards and frequency of donation: transcript of meeting. 2010; July 27.